LYDIA BESTERFELDT: Open Payments
NPI 1265929442 · MC LEAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 15 payments from 9 companies in 2025. Trend: 2023 $54 · 2024 $469 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $75 |
| Bausch Health US, LLC | 3 | $65 |
| ARGENX US, INC. | 2 | $47 |
| Lilly USA, LLC | 2 | $40 |
| TMS NeuroHealth Centers Inc. | 1 | $20 |
| Biogen, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: APLENZIN, VYVGART HYTRULO, UBRELVY, QULIPTA, TMS NeuroHealth Centers Inc., AMYVID, ZEPBOUND, LEQEMBI.
Industry payments across VA — which companies pay providers there.
